Covariates | Median survival time, In month (95% CL) | Overall 5-year Survival (%) | Log rank test | p–value |
---|---|---|---|---|
Age | 39.87 | < 0.001 | ||
< 30 | a | 81.45 | ||
30–39 | a | 56.51 | ||
40–49 | 39 (31.93–43.3) | 41.42 | ||
50–59 | 32.2 (27.37–38.46) | 21.29 | ||
≥ 60 | 30.37 (26.07–35) | 22.30 | ||
Substance | 10.63 | 0.0011 | ||
User | 32.2 (20.5–37.77) | 31.57 | ||
None User | 38.46 (35.93–47.7) | 39.62 | ||
FIGO Stage | 56.68 | < 0.001 | ||
I | a | 81.04 | ||
II | a | 67.94 | ||
III | 35 (30.37–37.87) | 23.33 | ||
IV | 28.87 (21.6–34.37) | 20.03 | ||
Anemic Status | 27.05 | < 0.001 | ||
Yes | 31.4 (28.87–36.53) | 30.26 | ||
No | a | 55.05 | ||
Comorbidity | 27.78 | < 0.001 | ||
Yes | 29.8 (26.33–33.17) | 21.55 | ||
No | 51.80 | |||
Aim RT | 21.05 | < 0.001 | ||
Radical | 46.53 (34.4–51.52) | 46.16 | ||
Palliative | 34.67 (30.03–37.3) | 32.57 | ||
No RT | a | 82.8 |